| mRNA |
Docetaxel |
GDSC1000 |
pan-cancer |
AAC |
0.18 |
1e-05 |
| mRNA |
Erlotinib |
CCLE |
pan-cancer |
AAC |
0.25 |
1e-05 |
| mRNA |
RDEA119 |
GDSC1000 |
pan-cancer |
AAC |
0.17 |
2e-05 |
| mRNA |
Cetuximab |
GDSC1000 |
pan-cancer |
AAC |
0.16 |
0.0001 |
| mRNA |
KIN001-055 |
GDSC1000 |
pan-cancer |
AAC |
0.15 |
0.0007 |
| mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.0008 |
| mRNA |
Gefitinib |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.0008 |
| mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0008 |
| mRNA |
PLX4720 |
CCLE |
pan-cancer |
AAC |
0.18 |
0.001 |
| mRNA |
compound 1B |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.001 |